Randomized trial · people

MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 year

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In healthy older adults, a year of daily MK-677 added fat-free mass and body weight but did not change strength or function, and it came with higher fasting glucose and lower insulin sensitivity.

Kind
Randomized trial
Studied in
People
Number studied
65
Published
2008
Journal
Ann Intern Med

What they tested

The team tested whether daily oral MK-677 could raise growth hormone to young-adult levels, prevent the loss of fat-free mass and cut belly fat around the organs in healthy older adults, without serious side effects.

How the study was done

A 2-year, double-blind (neither participants nor staff knew who got what), randomized, placebo-controlled trial with a modified crossover design in 65 healthy adults aged 60 to 81, who took 25 mg of MK-677 or a dummy pill by mouth once a day. Fat-free mass (everything in the body that isn't fat) and abdominal visceral fat were the main outcomes at 1 year.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking MK-677? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Growth hormone and insulin-like growth factor I (IGF-I) levels rose into the range of healthy young adults, with no serious side effects. Fat-free mass changed by 1.1 kg in the MK-677 group and -0.5 kg in the placebo group (P < 0.001), and body weight rose 2.7 kg versus 0.8 kg (P = 0.003); belly fat around the organs and total fat mass did not differ between groups, but limb fat rose more on MK-677 (1.1 kg vs. 0.24 kg). In the MK-677 group, fasting blood glucose went up by an average of 0.3 mmol/L (5 mg/dL), insulin sensitivity fell, and cortisol rose 47 nmol/L, while LDL cholesterol dropped 0.14 mmol/L from baseline. The most common side effects were a rise in appetite that faded within a few months and short-lived, mild swelling of the lower legs and muscle pain, and the gain in fat-free mass did not translate into changes in strength or function.

What it doesn’t show

The trial was too small and too short to judge effects on strength and day-to-day function, and it included only healthy older adults. The 2-year results were exploratory analyses.

The paper

Nass et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008.

The compound

More studies on MK-677

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking MK-677? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo